MK-8109 (Vintafolide)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MK-8109 (Vintafolide), covering 2015-02-10 to 2015-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001) [Phase 1]